# OnCo record orbimed (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/orbimed/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "orbimed" ;
  schema:name "OrbiMed"@en ;
  schema:description "OrbiMed is a New York healthcare investment firm managing about 20 billion dollars across venture, private equity, public equity and royalty strategies, with teams in North America, Europe and Asia. Its cancer portfolio includes Adcendo (antibody-drug conjugates), Adela (blood-based cancer detection), Adicet Bio (immune-cell therapies) and Alterome (alteration-specific drugs)."@en ;
  schema:url <https://onco.cc/companies/orbimed/>, <https://www.orbimed.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.orbimed.com/>, <https://www.orbimed.com/portfolio/>, <https://en.wikipedia.org/wiki/OrbiMed> ;
  onco:tag "vc" ;
  schema:addressCountry "US" .